Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer’s disease and neocortical Lewy body disease

  • 1.

    Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimer’s Dement. 13, 325–373 (2017).

  • 2.

    Whitfield, D. R. et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer’s disease: Association with cognitive impairment. Neurobiol. Aging 35, 2836–2844 (2014).

  • 3.

    Whitfield, D. R. et al. Depression and synaptic zinc regulation in Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease dementia. Am. J. Geriatr. Psychiatry 23, 1–8 (2014).

  • 4.

    Bereczki, E. et al. Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain 141, 582–595 (2018).

  • 5.

    Richter, R. W. & Richter, B. Z. Alzheimer’s Disease. (Spinger, 2004).

  • 6.

    Guo, T., Noble, W. & Hanger, D. P. Roles of tau protein in health and disease. Acta Neuropathologica 133, 665–704 (2017).

  • 7.

    Bereczki, E. et al. Synaptic proteins predict…

  • Read more…